SEC 13F Intelligence

Highvista Strategies LLC / IMVT

Highvista Strategies LLC’s Immunovant Inc Position

Does Highvista Strategies LLC own Immunovant Inc (IMVT)? Yes — 225.1K shares worth $6M (+1.54% of its 13F portfolio) as of Q1 2026, up from 221.9K shares the prior filed quarter.

Position Value
$6M
Q1 2026
Shares
225.1K
% of Portfolio
+1.54%
Quarters Held
11
currently held

Position History IMVT

Reported value by quarter
Q3 ’20: $630,000Q3 ’20Q4 ’20: $827,000Q1 ’23: $3MQ1 ’23Q2 ’23: $3MQ3 ’23: $4MQ3 ’23Q4 ’23: $5MQ1 ’25: $2MQ1 ’25Q2 ’25: $3MQ3 ’25: $4MQ3 ’25Q4 ’25: $6MQ1 ’26: $6MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026225.1K$6M+1.54%
Q4 2025221.9K$6M+1.45%
Q3 2025253.1K$4M+1.00%
Q2 2025182.8K$3M+1.07%
Q1 202595.6K$2M+0.63%
Q4 2023121.3K$5M+1.85%
Q3 2023106.9K$4M+1.90%
Q2 2023180.3K$3M+1.57%
Q1 2023163.8K$3M+2.07%
Q4 202017.9K$827,000+0.53%
Q3 202017.9K$630,000+0.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of IMVT.